[Oxidative stress marker].
Katayama
Shigehiro
S
Division of Endocrinology and Diabetes, Department of Medicine, School of Medicine, Faculty of Medicine, Saitama Medical University.
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000032:analysis; D015237:Dinoprost / Q000031:analogs & derivatives / Q000032:analysis; D017127:Glycation End Products, Advanced / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D008054:Lipid Peroxides / Q000032:analysis*; D008077:Lipoproteins, LDL / Q000032:analysis*; D008239:Lysine / Q000031:analogs & derivatives / Q000032:analysis; D018384:Oxidative Stress
D015415:Biomarkers; D017127:Glycation End Products, Advanced; D008054:Lipid Peroxides; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; C075750:8-epi-prostaglandin F2alpha; D000080242:8-Hydroxy-2'-Deoxyguanosine; D001120:Arginine; D015237:Dinoprost; C062187:pentosidine; D003849:Deoxyguanosine; D008239:Lysine